ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

The excision repair cross-complementation group 1 (ERCC1) enzyme plays a rate-limiting role in the nucleotide excision repair pathway and is associated with resistance to platinum-based chemotherapy. The purpose of this study was to evaluate the role of ERCC1 expression as a predictive marker of sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, H J, Ahn, M J, Kim, H S, Yi, S Y, Han, J, Lee, S K, Ahn, Y C, Jeong, H-S, Son, Y-I, Baek, J-H, Park, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453006/
https://www.ncbi.nlm.nih.gov/pubmed/18594541
http://dx.doi.org/10.1038/sj.bjc.6604464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453006/
https://www.ncbi.nlm.nih.gov/pubmed/18594541
http://dx.doi.org/10.1038/sj.bjc.6604464

Ejemplares similares